SCHEDULE.

WEDNESDAY, JUNE 9th
 Day 1: Child and Adolescent Depression

Opening Remarks

8:45am – 8:55am

Jeffrey A. Lieberman, MD (Columbia University)

Conference Overview

8:55 – 9:00am

J. John Mann, MD (Columbia University)

Day 1 Keynote:

Understanding, Treating and Preventing Depression: How Can Neuroscience Help? 

9:00 – 9:50am

Presenter:

Huda Akil, PhD (University of Michigan)

Session moderator:

J. John Mann, MD (Columbia University)

Break

9:50 – 10am

Session 1: Depression in Children and Adolescents

10:00 – 11:15am

Social Isolation, Movement and Depression—Biological Insights From Mice

Amir Levine, MD (Columbia University) 

From Neuroimaging to Real-Time Monitoring: Clarifying Interpersonal Markers for Depression and Suicide in Adolescents

Randy P. Auerbach, PhD, ABPP (Columbia University) 

 

Interpersonal Psychotherapy for Depressed Adolescents: Impact on Interpersonal Factors

Laura Mufson, PhD (Columbia University)

 

Session moderator:

Myrna Weissman, PhD (Columbia University)

Break

11:15 – 11:30am

Session 2: On-line diagnosis and therapeutics of mood disorders: reinventing psychiatry

11:30 – 12:30pm        

The Future of Mental Health Measurement

Robert Gibbons, PhD (University of Chicago) 

Digital Approaches for the Assessment and Treatment of Depression

David C. Mohr, PhD (Northwestern University) 

Session Moderator:

Ravi Shah, MD (Columbia University)

WEDNESDAY, JUNE 16th
Day 2: Mid-Life Depression

Welcoming and Day 2 Overview

8:50am – 9:00am      

Randy Auerbach, PhD (Columbia University)

Day 2 Keynote:

Getting Closer to Developing New Treatments for Mood Disorders Using Neural Risk Markers  from Infancy to Adulthood

9:00 – 9:50am            

Presenter:

Mary Phillips, MD (University of Pittsburgh)

Moderator:

Jonathan Posner, MD (Columbia University)

Break

9:50 – 10am

Session 3: Depression in Mid-Life

10:00 – 11:15am

How Animal Models Can Explain the Biology of Depression and the Action of Antidepressants Like Ketamine

Christine Denny, PhD (Columbia University) 

How Brain Imaging Explains Major Depression and Leads to New Treatment Approaches

J. John Mann, MD (Columbia University) 

How to Improve the Outcome for Treatment Resistant Depression

Steven Roose, MD (Columbia University) 

 

Moderator:

Lourival Baptista-Neto, MD (Columbia University)

Break

11:15 – 11:30am

Session 4: Psychedelics and old new-age treatment for mood disorders

11:30 – 12:30pm        

 

The Promise and Perils of Psychedelic Treatments

David Hellerstein, MD (Columbia University) 

Defeating Alcoholism and Substance Use Disorder with Ketamine

Elias Dakwar, MD (Columbia University)

Moderator:

Jeffrey A. Lieberman, MD (Columbia University)

WEDNESDAY, JUNE 23rd
Day 3: Depression, Suicide, and Resilience

Welcoming and Day 3 Overview

8:50am – 9:00am      

J. John Mann, MD (Columbia University) 

Day 3 Keynote:

New faster-acting antidepressants: Finding Options Beyond Ketamine

9:00 – 9:50am            

Presenter:

Carlos Zarate Jr, MD (National Institute of Mental Health)

 

Moderator:

David Hellerstein, MD (Columbia University)

Break

9:50 – 10am

Session 5: Causes and Prevention of Suicidal Behavior

10:00 – 11:15am        

Neurobiology of Suicide

Maura Boldrini, MD (Columbia University) 

Lipid Biomarkers of Suicide Risk

M. Elizabeth Sublette, MD, PhD (Columbia University) 

Using Ecological Momentary Assessment to Understand Suicidal Ideation

Barbara H. Stanley, PhD (Columbia University) 

Moderator:

Helen Blair Simpson, MD, PhD (Columbia University)

Break

11:15 – 11:30am

Session 6: Resilience Research into Practice 

11:30 – 12:30pm        

The Neuroscience of Building Resilience

Golnaz Tabibnia, PhD (University of California – Irvine)

Risk & Resilience in UK Emergency Responders

Jennifer Wild, PhD (University of Oxford)

Evidence-Based Resilience for Frontline Workers

Lauren Peccoralo, MD, MPH (Icahn School of Medicine at Mount Sinai)

 

Moderator:

Jeff Thompson, PhD (Columbia University)